Windlas Biotech Ltd

NSE:WINDLASHealthcare

₹906.10−1.23%At closeAt close · Mon 19 Oct · ≈ AED 35.01 · Market cap $199.37M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	TTM	YoY
Revenue	4.3	4.6	5.1	6.3	7.6	9.0	9.4	+4.2%
Cost of revenue	2.7	3.0	3.3	4.0	4.7	7.4	7.8	+4.7%
Gross profit	1.5	1.6	1.8	2.3	2.9	1.6	1.7	+1.9%
Research & development	0.0	0.1	0.1	0.1	0.1	0.0	—	—
Selling, general & administrative	0.1	0.2	0.2	0.3	0.2	0.9	—	—
Selling & marketing	0.1	0.1	0.1	0.2	0.2	0.0	—	—
Operating expenses	0.2	1.2	0.4	0.5	2.2	0.9	0.9	+2.9%
Operating income	0.4	0.4	0.5	0.7	0.7	0.7	0.7	+0.5%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.1	+12.3%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	(0.2)	0.1	0.1	0.1	0.1	0.1	—	—
Pre-tax income	0.2	0.5	0.6	0.8	0.8	0.9	0.9	−0.4%
Income tax	0.1	0.1	0.1	0.2	0.2	0.2	0.2	−1.5%
Net income	0.2	0.4	0.4	0.6	0.6	0.7	0.7	−0.0%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	8.69	18.58	19.70	27.97	29.17	31.60	31.73	+0.4%
EPS, diluted (per share)	8.70	18.58	19.70	27.88	28.90	31.15	31.26	+0.4%
EBITDA	0.4	0.6	0.7	0.9	1.1	1.0	1.0	+0.1%
Depreciation & amortization	0.1	0.1	0.1	0.1	0.3	0.3	—	—
Weighted average shares (shares)	18,220,708	20,497,174	21,635,920	20,803,361	20,907,383	21,030,000	—	—
Weighted average diluted shares (shares)	18,207,419	20,497,174	21,635,920	20,872,745	21,105,691	21,334,000	—	—
Gross margin	35.7%	34.6%	35.5%	36.3%	37.9%	18.1%	17.7%	−0.4 pts
Operating margin	10.2%	8.7%	9.4%	10.4%	8.7%	8.2%	7.9%	−0.3 pts
Net margin	3.7%	8.2%	8.3%	9.3%	8.0%	7.4%	7.1%	−0.3 pts

INR billionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.